x
ServiziMenu principaleHome
You are here: Home > What we do > Future Events > EEBR Lung Cancer Refresher
Print

Description

Chairs: T. Cufer- SI, D. Jovanovic, RS

The Refresher Course on Lung Cancer is designed for medical and clinical oncologists of the Eastern Europe and Balkan Region in order to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field of lung cancer.

The programme will offer educational lectures covering updates and future directions in diagnostic and treatment approaches in lung cancer; while real life case discussions will provide an ideal opportunity for multidisciplinary discussion. By presenting real life cases young oncologist will get an ideal opportunity to learn on how to best present and discuss their cases.

LEARNING OBJECTIVES

• Update on pathology and molecular testing in lung cancer
• Update on the latest advances in diagnostic procedures
• Update on the latest advances in targeted therapy and immunotherapy for lung cancer
• Update on modern surgical and radiation therapy approaches in lung cancer
• Get acquainted and put into perspective the latest guidelines
• Learn about the management of specific situations on lung cancer
• Debate controversies and challenges in lung cancer treatment
• Improve practical skills in multidisciplinary discussion and management of lung cancer patients

Information

OFFICIAL LANGUAGE

The official language will be English. No translation will be available.

CME ACCREDITATION

The Refresher course on Lung Cancer will be accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

PARTICIPATION

Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended a previous Eastern Europe and Balkan Region Masterclass and or those practicing in this region.

Each past masterclass participant will be able to invite one colleague to apply, and further interested medical/clinical oncologists will be able to apply too.

Applicants who have not attended a previous Eastern Europe and Balkan Region Masterclass in Medical/Clinical Oncology should meet the following profile:

  • Age between 30 and 45 years
  • At least 2-3 years’ experience in medical oncology
  • Fluency in English
  • Practicing in Eastern Europe and Balkan Region

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on 22 April and departure on 24 April will be provided to participants not residing in the Vodice area.

ORGANISING SECRETARIAT

Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net

Application

APPLICATION 

Interested candidates should apply online providing:

If a candidate is not a past participant of a previous Eastern Europe and Balkan Region Masterclass, the following documents should also be provided together with application template and abstract:

  • Letter describing motivation for attending
  • Short CV (template provided) with the list of publications (if the list of publication is not
    provided, it will be assumed that no articles have been published)

ABSTRACT

Applicants are requested to submit an abstract describing a clinical case related to lung cancer. Some admitted participants will have the opportunity to present the clinical case in the format of a clinical grand round discussion to the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by the end of February.

APPLICATION DEADLINE:   21st January 2022

Programme

22 April

18:00 Registration
19:30 Dinner

23 April

8:30 Welcome address and general introduction
Tanja Cufer, SI - Dragana Jovanovic, RS
8:40 Lung cancer and COVID-19
9:00 Screening for lung cancer: pros and cons
9:30 Histopathological diagnosis and molecular testing of lung cancer
10:00 EBUS/TNBA in diagnosis and staging of lung cancer
10:30 Coffee break
11:00 Radiological methods to assist primary diagnostics and treatment tailoring
11:30 Surgery for early NSCLC and SCLC
12:00 Lunch
13:30 Adjuvant/neoadjuvant systemic therapy for early stage NSCLC
Tanja Cufer, SI
14:00 Radiotherapy in combination with systemic therapies – a final answer for Stage III NSCLC?
14:30 Stereotactic radiotherapy - how to proceed in lung cancer?
15:00 Management of oligometastatic lung cancer -dilemmas and opportunities
Dragana Jovanovic, RS
15:30 Coffee break
16:00 Tumour board
19:00 Dinner

24 April

8:30 Systemic therapy for lung cancer: Recent advances and future perspectives
9:00 New frontiers in immunotherapy of lung cancer
9:30 Update on targeted therapy for NSCLC
10:00 Novel targets and molecular driven therapies in NSCLC
10:30 Coffee break
11:00 Treatment of SCLC
Dragana Jovanovic, RS
11:30 Tumour board
13:00 Closing remarks
Tanja Cufer, SI - Dragana Jovanovic, RS